114 related articles for article (PubMed ID: 16338135)
1. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.
Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Tang W; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Salowe SP; Zaller DM; Scolnick EM; Schmatz DM; Bartizal K; Hermes JD; MacCoss M; Chapman KT
Bioorg Med Chem Lett; 2006 Feb; 16(4):964-8. PubMed ID: 16338135
[TBL] [Abstract][Full Text] [Related]
2. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
Schepetkin IA; Khlebnikov AI; Kirpotina LN; Quinn MT
J Med Chem; 2006 Aug; 49(17):5232-44. PubMed ID: 16913712
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of anthrax lethal factor.
Gaddis BD; Avramova LV; Chmielewski J
Bioorg Med Chem Lett; 2007 Aug; 17(16):4575-8. PubMed ID: 17574849
[TBL] [Abstract][Full Text] [Related]
4. Anthrax lethal factor inhibition.
Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
Park HC; Sung SR; Lim SM; Lee JS; Kim SK; Yoon MY
Microb Pathog; 2012 Aug; 53(2):109-12. PubMed ID: 22561400
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
Gaddis BD; Rubert Pérez CM; Chmielewski J
Bioorg Med Chem Lett; 2008 Apr; 18(7):2467-70. PubMed ID: 18314330
[TBL] [Abstract][Full Text] [Related]
7. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
[TBL] [Abstract][Full Text] [Related]
8. 4-[5-Fluoro-3-[4-(2-methyl-1H-imidazol-1-yl)benzyloxy]phenyl]-3,4,5,6- tetrahydro-2H-pyran-4-carboxamide, an orally active inhibitor of 5-lipoxygenase with improved pharmacokinetic and toxicology characteristics.
Mano T; Okumura Y; Sakakibara M; Okumura T; Tamura T; Miyamoto K; Stevens RW
J Med Chem; 2004 Jan; 47(3):720-5. PubMed ID: 14736252
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.
Giblin GM; O'Shaughnessy CT; Naylor A; Mitchell WL; Eatherton AJ; Slingsby BP; Rawlings DA; Goldsmith P; Brown AJ; Haslam CP; Clayton NM; Wilson AW; Chessell IP; Wittington AR; Green R
J Med Chem; 2007 May; 50(11):2597-600. PubMed ID: 17477516
[TBL] [Abstract][Full Text] [Related]
10. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.
Montecucco C; Tonello F; Zanotti G
Trends Biochem Sci; 2004 Jun; 29(6):282-5. PubMed ID: 15276179
[TBL] [Abstract][Full Text] [Related]
11. A novel pharmacophore model for the design of anthrax lethal factor inhibitors.
Yuan H; Johnson SL; Chen LH; Wei J; Pellecchia M
Chem Biol Drug Des; 2010 Sep; 76(3):263-8. PubMed ID: 20572812
[TBL] [Abstract][Full Text] [Related]
12. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput screening approach to anthrax lethal factor inhibition.
Johnson SL; Chen LH; Pellecchia M
Bioorg Chem; 2007 Aug; 35(4):306-12. PubMed ID: 17320146
[TBL] [Abstract][Full Text] [Related]
14. Rhodanine derivatives as selective protease inhibitors against bacterial toxins.
Johnson SL; Chen LH; Harbach R; Sabet M; Savinov A; Cotton NJ; Strongin A; Guiney D; Pellecchia M
Chem Biol Drug Des; 2008 Feb; 71(2):131-9. PubMed ID: 18221310
[TBL] [Abstract][Full Text] [Related]
15. Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.
Roy J; Kumar UC; Machiraju PK; Muttineni RK; Kumar B V S S; Gundla R; Dayam R; Sarma JA
J Mol Graph Model; 2010 Sep; 29(2):256-65. PubMed ID: 20727800
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin.
Lee YS; Bergson P; He WS; Mrksich M; Tang WJ
Chem Biol; 2004 Aug; 11(8):1139-46. PubMed ID: 15324815
[TBL] [Abstract][Full Text] [Related]
17. Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist.
Zheng C; Cao G; Xia M; Feng H; Glenn J; Anand R; Zhang K; Huang T; Wang A; Kong L; Li M; Galya L; Hughes RO; Devraj R; Morton PA; Rogier DJ; Covington M; Baribaud F; Shin N; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B; Xue CB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1442-6. PubMed ID: 21295478
[TBL] [Abstract][Full Text] [Related]
18. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
[TBL] [Abstract][Full Text] [Related]
19. Combating the threat of anthrax: a quantitative structure-activity relationship approach.
Verma RP; Hansch C
Mol Pharm; 2008; 5(5):745-59. PubMed ID: 18611038
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.
Gujraty KV; Joshi A; Saraph A; Poon V; Mogridge J; Kane RS
Biomacromolecules; 2006 Jul; 7(7):2082-5. PubMed ID: 16827573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
